Dr. David Chen, MD

Dr. Chen practices at Dallas Neuroscience, P.A. in Desoto, Texas.

Dr. Chen's NPI, 1609868918, was assigned on August 22, 2005. Dr. Chen graduated from University of Pittsburgh School of Medicine in 1987. Dr. Chen holds Texas license H9019.

Dr. Chen's primary practice is Dallas Neuroscience, P.A., at 1001 Robbie Mince Way, Desoto, TX 75115 in Dallas County. The practice phone is (214) 941-7655.

Dr. Chen's primary practice is Dallas Neuroscience, P.A. in Desoto, Texas. The medical group on file is Dallas Neuroscience, P.A. Dmand AI also links Dr. Chen to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chen practices. Vendor and product names are available with a free account.

Neurology is Dr. Chen's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Chen is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Chen is licensed in Texas.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain and hereditary polyneuropathy among the conditions Dr. Chen treats.

CMS data shows 648 Medicare services from Dr. Chen across 14 procedure codes in 2024, for 180 Medicare patients. Medicare paid $114,062 for them. Every service was in an office.

CMS counts 180 Medicare patients who saw Dr. Chen in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chen's median patient age at 69, with 61% women.

In 2024, Dr. Chen wrote 2,020 Medicare Part D claims for 444 patients. 94% of them were for generic drugs. CMS names the drug for 1,885 of them, across 32 drugs with 11 or more claims each, at $165,794 in total drug cost. In 2023, CMS named 1,879 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Chen for performance year 2024, reported as part of a group. Dr. Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chen as offering telehealth.

Dmand AI links 86 papers to Dr. Chen, published from 2001 to 2021. 2014 was the busiest year, with 5. The most frequent topics are DNA-Binding Proteins, Electroencephalography and Seizures. Dr. Chen has published most often in Epilepsy Behav. Dr. Chen's most frequent co-authors are David J. Chen, MD, Selim Ramin Benbadis, MD and Andrew S. Blum, MD, PhD.

CMS Open Payments shows 119 general payments to Dr. Chen from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. UCB, Inc. paid the most, $991.

Dr. Chen graduated from University of Pittsburgh School of Medicine in 1987.

Dr. Chen is in network with 21 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.